Talis Biomedical Corporation - common stock (NQ:TLIS)

4.380 UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Talis Biomedical Corporation - common stock

< Previous 1 2 3 4 5 6 Next >

Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 21, 2023

Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak...

Via Benzinga

Why Advanced Health Intelligence Shares Are Trading Higher By 111%; Here Are 20 Stocks Moving Premarket ↗

June 21, 2023

Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares gained 110.8% to $1.56 in pre-market trading after the company signed a Letter of Intention with UAE-Based e-script medicine management...

Via Benzinga

Talis Biomedical: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Talis Biomedical's Return On Capital Employed Overview ↗

March 23, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 19, 2022

On Wednesday, 200 companies hit new 52-week lows.

Via Benzinga

Talis Biomedical Stops Work On COVID-19 Assay, Cuts Workforce ↗

August 03, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 21, 2023

It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Wednesday morning!

Via InvestorPlace

Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director

May 23, 2023

From Talis Biomedical Corporation

Via GlobeNewswire

Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results

May 11, 2023

Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific

From Talis Biomedical Corporation

Via GlobeNewswire

Earnings Scheduled For May 11, 2023 ↗

May 11, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...

Via Benzinga

Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023

May 04, 2023

From Talis Biomedical Corporation

Via GlobeNewswire

Talis Biomedical Corporation (TLIS) Stockholders: Robbins LLP is Investigating TLIS on Behalf of Shareholders

May 02, 2023

From Robbins LLP

Via Business Wire

Talis Announces Fourth Quarter and Full Year 2022 Financial Results

March 22, 2023

From Talis Biomedical Corporation

Via GlobeNewswire

Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session ↗

December 05, 2022

Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share.

Via Benzinga

Talis Biomedical Reports Third Quarter 2022 Financial Results

November 03, 2022

From Talis Biomedical Corporation

Via GlobeNewswire

This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday ↗

August 18, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 25, 2022

On Tuesday, 120 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 17, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 16, 2022

Via Benzinga

This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket ↗

August 03, 2022

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 02, 2022

Tuesday's session saw 63 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 19, 2022

Gainers Talis Biomedical (NASDAQ:TLIS) shares moved upwards by 10.6% to $0.94 during Tuesday's after-market session. The company's market cap stands at $25.0 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

July 28, 2022

On Thursday, 108 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 27, 2022

Wednesday saw 83 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

June 15, 2022

Wednesday's session saw 269 companies set new 52-week lows.

Via Benzinga

Talis Biomedical Earnings Perspective: Return On Capital Employed ↗

June 14, 2022

Benzinga Pro data, Talis Biomedical (NASDAQ:TLIS) reported Q1 sales of $3.19 million. Earnings fell to a loss of $33.05 million, resulting in a 15.35% decrease from last quarter.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 25, 2022

On Wednesday, 215 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 10, 2022

Gainers Avalon Globocare (NASDAQ:AVCO) stock rose 14.8% to $0.54 during Tuesday's after-market session. The market value of their outstanding shares is at $47.8 million.

Via Benzinga

NASDAQ:TLIS Long Term Investor Alert: Investigation of Potential Wrongdoing at Talis Biomedical Corporation ↗

May 10, 2022

San Diego, CA -- (SBWIRE) -- 05/10/2022 -- Certain directors of Talis Biomedical Corporation are under investigation over potential breaches of fiduciary duties.

Via SBWire

Earnings Scheduled For May 10, 2022 ↗

May 10, 2022

Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.